Dimensional Fund Advisors
CYT

Dimensional Fund Advisors’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

Dimensional Fund Advisors’s Portfolio CYT Stock Details CYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-21,064
Closed -$54.8K – 3518
2023
Q2 		$54.8K Buy
+21,064
New +$44.1K ﹤0.01% 3401

Other funds holding CYT

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
VAS
VR Advisory Services Camana Bay, Grand Cayman, Cayman Islands $845M AUM 22.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

Dimensional Fund Advisors's CYT Position: Q3 2023 in Review

Dimensional Fund Advisors sold out of Cyteir Therapeutics, Inc. Common Stock (CYT) in Q3 2023, closing a stake of 21,064 shares — an estimated $54.8K sold.

Dimensional Fund Advisors first reported a position in CYT in Q2 2023 and held it in 1 quarter. The position peaked at $54.8K in Q2 2023. 41 funds tracked by Wall St. Rank hold CYT as of Q3 2023.

  • Dimensional Fund Advisors reported no remaining Cyteir Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 21,064 Cyteir Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $54.8K.
  • Dimensional Fund Advisors first reported a position in Cyteir Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Dimensional Fund Advisors's Cyteir Therapeutics, Inc. Common Stock position peaked at $54.8K in Q2 2023.
  • 41 funds tracked by Wall St. Rank held Cyteir Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Dimensional Fund Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.